{"id":"spm-929","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"10-20%","effect":"Headache"},{"rate":"5-10%","effect":"Dizziness"},{"rate":"5-10%","effect":"Insomnia"},{"rate":"5-10%","effect":"Fatigue"}]},"_chembl":null,"_fixedAt":"2026-03-30T17:51:37.903532","_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By increasing serotonin levels, SPM 929 helps to improve mood, reduce anxiety, and alleviate symptoms of depression. This is achieved through the inhibition of the serotonin transporter, allowing more serotonin to be available for binding to its receptors in the brain.","oneSentence":"SPM 929 is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the levels of serotonin in the brain.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:53:24.029Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Major depressive disorder"},{"name":"Generalized anxiety disorder"}]},"_fixedFields":["pubmed(9)"],"trialDetails":[{"nctId":"NCT00350103","phase":"PHASE3","title":"A Trial to Assess the Efficacy and Safety of 400mg/Day Lacosamide in Subjects With Painful Diabetic Neuropathy","status":"COMPLETED","sponsor":"UCB Pharma","startDate":"2006-06-30","conditions":"Painful Diabetic Neuropathy","enrollment":551}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":9,"recentPublications":[{"date":"2025 Sep 26","pmid":"41150985","title":"Impacto de nuevos fármacos y calidad de la atención en trabajadores con diabetes.","journal":"Salud publica de Mexico"},{"date":"2025 Feb 20","pmid":"39977203","title":"Survey of antibiotic use at a tertiary care hospital in Mexico.","journal":"Salud publica de Mexico"},{"date":"2023 Sep 15","pmid":"38060912","title":"Motoric cognitive risk syndrome and its association with falls: a secondary analysis of the Mexican Health and Aging Study.","journal":"Salud publica de Mexico"},{"date":"2022 Mar 8","pmid":"35327746","title":"Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease.","journal":"Children (Basel, Switzerland)"},{"date":"2021 Feb 26","pmid":"33989492","title":"Desigualdades de género en la utilización de servicios sanitarios, España 2006-2017.","journal":"Salud publica de Mexico"}],"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Lacosamide"],"phase":"phase_3","status":"active","brandName":"SPM 929","genericName":"SPM 929","companyName":"UCB Pharma","companyId":"ucb","modality":"Small molecule","firstApprovalDate":"","aiSummary":"SPM 929 is a selective serotonin reuptake inhibitor (SSRI) that works by increasing the levels of serotonin in the brain. Used for Major depressive disorder, Generalized anxiety disorder.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":1},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}